Original ArticleBYAKANGELICIN (cas 19573-01-4) as a modulator for improved distribution and bioactivity of natural compounds and synthetic drugs in the brain

Add time:08/24/2019    Source:sciencedirect.com

BackgroundThe elucidation of the biological roles of individual active compounds in terms of their in vivo bio-distribution and bioactivity could provide crucial information to understand how natural compounds work together as treatments for diseases.

We also recommend Trading Suppliers and Manufacturers of BYAKANGELICIN (cas 19573-01-4). Pls Click Website Link as below: cas 19573-01-4 suppliers

Prev:Original articleNew luminescent cyclometalated iridium(III) complexes containing fluorinated phenylisoquinoline-based ligands: Synthesis, structures, photophysical properties and DFT calculations
Next:Effect of BYAKANGELICIN (cas 19573-01-4), an aldose reductase inhibitor, on galactosemic cataracts, the polyol contents and Na+, K+ATPase activity in sciatic nerves of strepto-zotocin-induced diabetic rats1)